SHARE

AstraZeneca and Sun Pharma partner to expand hyperkalaemia treatment access in India

The companies will aim to reach more chronic kidney disease and heart failure patients with AstraZeneca selling Lokelma and Sun Pharma marketing Gimliand. AstraZeneca retains IP, marketing authorisation and the import licence.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.